The Pharmacology of Second Generation Neuroleptics

Slides:



Advertisements
Similar presentations
Treating Schizophrenia in Low And Middle Income (LAMI) Countries: Challenges and opportunities Treating Schizophrenia in Low And Middle Income (LAMI) Countries:
Advertisements

PHL. 322 Final lab Presented by Mohammed Alyami Teaching assistant Department of pharmacology & Toxicology College of pharmacy KSU.
conventional antipsychotic drug
Antipsychotic Medications
Dopamine Theory of Schizophrenia
Psychopharmacology - Antipsychotic drugs
Development and Utilization of Drug For Treating Psychotic Disorders: How Well Have US Federal and State Policies/ Laws Served Individual and Societal.
Guy Brookes Leeds PFT.  Antipsychotic Medication  Antidepressant Medication  Mood Stabilisers  What does the Evidence mean?
Psychopharmacology: Anti-psychotic Medications
Drugs Used to Treat Schizophrenia
 incidence  characteristics  causes?  treatments?
Intro to Psychopharmacology Caitlin Stork, MD. Besides dopamine blockade... ReceptorEffect of Blockade Acetylcholine (muscarinic; M1) Anticholinergic.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care Guidance on.
Schizophrenia and Antipsychotic Treatment Stacy Weinberg 3 April 2007.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 31 Antipsychotic Agents and Their Use in Schizophrenia.
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder:
The Clinical Antipsychotic Trials of Intervention Effectiveness Trial
Implementing NICE guidance
What is psychosis? D B Double
Next-Generation Strategies for the Therapeutic Management of Schizophrenia Diana O. Perkins, MD, MPH Professor, Department of Psychiatry Medical Director.
Antipsychotic drugs. Anti-psychotic drugs The CNS functionally is the most complex part of the body, and understanding drug effects is difficult Understanding.
OPTIMAL TREATMENT INTERVENTIONS IN RECENT-ONCET PSYCHOSIS Vassilis P. Kontaxakis Associate Professor of Psychiatry, University of Athens.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 16Psychopharmacology.
A meta-analysis, of the efficacy of second generation antipsychotics (SGAs) 142 controlled studies were reviewed 124 studies of SGAs vs FGA, patients.
Introduction: Medical Psychology and Border Areas
ANTIPSYCHOTIC. What do antipsychotics treat?  Psychotic Disorders (Psychosis) Abnormal Thinking and Perceptions Loss of Contact with Reality Delusions.
Using Recent Research to Improve the Cost-Effectiveness of VA Antipsychotic Formulary Policy Robert Rosenheck MD Michael Sernyak MD New England MIRECC.
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
IEPA clinical practice guidelines for ARMS Shôn Lewis University of Manchester UK.
MANAGEMENT of FIRST-EPISODE PSYCHOSIS H.Amini M.D. Roozbeh Hospital Tehran University of Medical Sciences.
Medical Care. Antipsychotic medications mainstay of treatment for schizophrenia 2 Types of Antipsychotics Conventional or 1 st generation – Dopamine 2.
Treatment of Schizophrenia THE DEBATE OF THE YEAR! EFFICACY vs. TOLERABILITY: WHICH TRUMPS? POINT- COUNTERPOINT.
How antipsychotics work: Attaching to receptors and changing reality
Antipsychotic agents By S.Bohlooli PhD.
ANTIPSYCHOTICS Katy and Zoë. Psychosis Mental disorder with a broad range of symptoms. Patients ‘lose touch with reality’ and present with: hallucinations.
Practice pharmacology, medical students III.yr. November 2013
Schizophrenia: Etiology and Treatment
Schizophrenia Pathogenesis is unknown. Onset of schizophrenia is in the late teens - early ‘20s. Genetic predisposition -- Familial incidence. Multiple.
Teresa Hudson, PharmD Center for Mental Healthcare and Outcomes Research South Central Mental Illness Research Education and Clinical Center.
بسم الله الرحمن الرحيم Dr: Samah Gaafar Hassan Al-shaygi.
Prescribing in Dementia. Plan What to prescribe? When to prescribe? How to review? Who to review?
WPA Atypical or Second Generation Neuroleptics. WPA Period 4: BPRS Total Score During Double-Blind Period.
for MHD & Therapeutics is proud to present And Now Here Is The Host... Dr. Schilling.
BIPOLAR DISORDER, DR GIAN LIPPI CONSULTANT PSYCHIATRIST UNIVERSITY OF PRETORIA & WESKOPPIES HOSPITAL FORENSIC UNIT MANAGEMENT GUIDELINES.
Biological Therapies for Schizophrenia. An Introduction Prior to introduction of antipsychotic drugs there was no effective treatment for schizophrenia.
Management of Geriatric Psychiatric Disorders Arash Mirabzadeh Psychiatrist University of Social Welfare and Rehabilitation Sciences.
思覺失調症 精神科主治醫師 游佩琳.
Pharmacological management of delirium
抗精神失常药 PHARMACOLOGY OF ANTIPSYCHOTIC DRUGS (NEUROLEPTICS)
Addressing Partial-Response or Non-Response
Module 3 Indications Antipsychotics for Schizophrenia
Antipsychotic Agents and Their Use in Schizophrenia
Expert Perspectives on New Treatment Options for Parkinson Disease Psychosis.
Antipsychotic-Induced Dysphagia
Antipsychotic Agents and Their Use in Schizophrenia
Pharmacodynamics: How do antipsychotic medications work?
Antipsychotics: chemistry and pharmacokinetics
Chapter 12: Therapy.
Antipsychotic (Neuroleptic) Drugs
University of Nizwa College of Pharmacy and Nursing School of Pharmacy
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Antipsychotic Agents & Schizophrenia
Antipsychotic Drugs (Neuroleptics, Major Tranquillisers)
1 in 100 people have had a schizophrenia episode. more than 2
Risperidone – Binding Profile
Dr James Ovens Consultant Psychiatrist Tandridge CMHRS
Antipsychotics: The Essentials Module 2 Mechanism of Action First and Second Generation Antipsychotics In this module I talk about the mechanism of action.
Topic Discussion By Alexandria Brown
Presentation transcript:

The Pharmacology of Second Generation Neuroleptics

Structure of Serotonin

Distribution of Serotonin

Combined Serotonin and Dopamine Pathways

Receptor Binding Affinities of Three Atypical Antipsychotics 5-HT2A 5-HT2C AChM H1 a2 a1 Risperidone 10 1 0.1 0.01 0.001 0.0001 Clozapine 5-HT2A 5-HT2C AChM H1 a2 a1 D2 10 1 0.1 0.01 0.001 0.0001 Olanzapine 5-HT2A 5-HT2C AChM H1 a1 D2 10 1 0.1 0.01 0.001 0.0001 (No data available for a2-receptors) Kasper, Data from:Schotte et al., 1996

Neuroleptic Receptor Pies D1 D2 5-HT2A 5-HT1A A1 A2 H1 Muscarinic Clozapine Olanzapine Quetiapine Sertindole Ziprasidone Risperidone Haloperidol

In Humans the Effects Are a Function of Dose Receptor-pies Reflect an Abstract Concept In Humans the Effects Are a Function of Dose D2 D2 5-HT2 D2 5-HT2 5-HT2 5-HT2 5-HT2 D2 D2

Using Imaging Tools to Develop Rational Dosing Strategies

D2 Receptor Binding The ligand C11- Raclopride is injected prior to PET study. Areas of high uptake (high D2 occupancy) are shown in red.

Haloperidol and D2 Occupancy 11C-Raclopride PET Scan 11C-Raclopride PET Scan Coregistered MRI Scan Before Treatment Haloperidol 2 mg/d (74% Occ.)

D2 Occupancy Predicts Clinical Response D2 occupancy predicts response on CGI (p < 0.001) Predicts change in positive symptoms (p = 0.07) Kapur et al. Am. J Psychiatry, 2000

D2 Occupancy Predicts EPS/akathisia Subjects with EPS or akathisia 78% NO subject < 78% showed EPS/akathisia Kapur et al. American Journal of Psychiatry, 2000.

D2 Occupancy Predicts Prolactin Elevation 2 of 15 show prolactin elevation below 72%D2 5 of 6 show prolactin elevation above 72%D2 D2 occupancy predicts prolactin elevation (F1,20 = 7.3, p < 0.01)

Risperidone 5-HT2 & D2 Occupancy Threshold for EPS Threshold for Response EPS Kapur, Zipursky and Remington, American Journal of Psychiatry, 1999.

Olanzapine 5-HT2 & D2 Occupancy EPS + Prolactin * EPS and/or prolactin elevation Kapur, Zipursky and Remington, American Journal of Psychiatry, 1999.

Practical Aspects of Treatment

Practical Issues Dosage Use of Anticholinergics Oral vs. Depot Neuroleptics Reducing or Discontinuing Medication Long-term Outcome Early intervention

Can Early Intervention Prevent Disease Progression? Early diagnosis is difficult It is also hampered by stigma There is minimal to no evidence for a direct toxic brain effect of untreated psychosis However, the psychological impact of untreated psychosis may be significant

Psychosocial Treatments

Psychosocial Strategies Facilitation of pharmcotherapy Token economy system Carer-based stress management Living skills training Social case management Educational Techniques and Family Therapy Cognitive-Behavioral Interventions Sustaining the benefits